MD1716C2 - Use of melatonin for treatment of patients dependent on benzodiazepine - Google Patents
Use of melatonin for treatment of patients dependent on benzodiazepineInfo
- Publication number
- MD1716C2 MD1716C2 MD97-0254A MD970254A MD1716C2 MD 1716 C2 MD1716 C2 MD 1716C2 MD 970254 A MD970254 A MD 970254A MD 1716 C2 MD1716 C2 MD 1716C2
- Authority
- MD
- Moldova
- Prior art keywords
- treatment
- melatonin
- benzodiazepine
- benzodiazepinic
- dependence
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The invention relates to the melatonin use for treatment of polymedicinal dependence, for treatments of the patient with symptoms of tolerance, dependence on benzodiazepinic medicines or of the patient with a state susceptible of calmness by administration of a benzodiazepinic medicine, simultaneously preventing appearance to him of the symptoms of dependence, tolerance or excess of benzodiazepinic medicines.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/381,535 US6469044B1 (en) | 1995-02-01 | 1995-02-01 | Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies |
EP95303853A EP0724878B1 (en) | 1995-02-01 | 1995-06-06 | Use of melatonin for treating patients suffering from drug dependencies |
PCT/IB1996/000082 WO1996023496A1 (en) | 1995-02-01 | 1996-01-29 | Use of melatonin for treating patients suffering from drug addiction |
Publications (3)
Publication Number | Publication Date |
---|---|
MD970254A MD970254A (en) | 1999-05-31 |
MD1716B2 MD1716B2 (en) | 2001-08-31 |
MD1716C2 true MD1716C2 (en) | 2002-02-28 |
Family
ID=26140195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MD97-0254A MD1716C2 (en) | 1995-02-01 | 1996-01-29 | Use of melatonin for treatment of patients dependent on benzodiazepine |
Country Status (22)
Country | Link |
---|---|
JP (1) | JP4516159B2 (en) |
CN (1) | CN1083263C (en) |
AT (1) | AT408188B (en) |
AU (1) | AU695366B2 (en) |
BG (1) | BG62876B1 (en) |
BR (1) | BR9607169A (en) |
CZ (1) | CZ291349B6 (en) |
DK (1) | DK176081B1 (en) |
EE (1) | EE03384B1 (en) |
FI (1) | FI119586B (en) |
IS (1) | IS1980B (en) |
LU (1) | LU90118B1 (en) |
LV (1) | LV11940B (en) |
MD (1) | MD1716C2 (en) |
NO (1) | NO312814B1 (en) |
NZ (1) | NZ298878A (en) |
PL (1) | PL183148B1 (en) |
SI (1) | SI9620022A (en) |
SK (1) | SK284521B6 (en) |
TR (1) | TR199700723T1 (en) |
TW (1) | TW483757B (en) |
WO (1) | WO1996023496A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60034373T2 (en) | 2000-01-05 | 2007-12-20 | Neurim Pharmaceuticals (1991) Ltd. | METHOD AND COMPOSITION FOR TREATING RESISTANCE TO ANTI-HYPERTENSIVE AND RELATED STATES |
IL149377A (en) * | 2002-04-28 | 2012-10-31 | Neurim Pharma 1991 | Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds |
IL155666A (en) | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Composition for treating insomnia |
US9119846B2 (en) | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
US11918557B2 (en) | 2012-01-26 | 2024-03-05 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
BR112014018429A8 (en) | 2012-01-26 | 2017-07-11 | Vanda Pharmaceuticals Inc | METHOD FOR TREATMENT OF A PATIENT SUFFERING FROM NON-24, AND METHOD FOR THE CHRONIC TREATMENT OF NON-24 IN A PERSON WHO IS TOTALLY BLIND |
AU2013361459A1 (en) | 2012-12-18 | 2015-07-02 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
US11090285B2 (en) | 2013-11-12 | 2021-08-17 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
US10376487B2 (en) | 2013-11-12 | 2019-08-13 | Vanda Pharmaceuticals Inc. | Method of treatment |
JP6830156B2 (en) * | 2016-10-31 | 2021-02-17 | ニューリム・ファーマシューティカルズ・リミテッドNeurim Pharmaceuticals Ltd. | Melatonin mini tablet and its manufacturing method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0513702A2 (en) * | 1991-05-13 | 1992-11-19 | I.F.L.O. ISTITUTO FARMACOLOGICO LOMBARDO S.A.S. di Giorgio & Aldo Laguzzi & C. | Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication |
EP0518468A1 (en) * | 1991-05-09 | 1992-12-16 | Neurim Pharmaceuticals (1991) Limited | Melatonin containing compositions |
-
1996
- 1996-01-29 TR TR97/00723T patent/TR199700723T1/en unknown
- 1996-01-29 SI SI9620022A patent/SI9620022A/en not_active IP Right Cessation
- 1996-01-29 AT AT0901396A patent/AT408188B/en not_active IP Right Cessation
- 1996-01-29 WO PCT/IB1996/000082 patent/WO1996023496A1/en active IP Right Grant
- 1996-01-29 NZ NZ298878A patent/NZ298878A/en not_active IP Right Cessation
- 1996-01-29 MD MD97-0254A patent/MD1716C2/en not_active IP Right Cessation
- 1996-01-29 BR BR9607169A patent/BR9607169A/en not_active Application Discontinuation
- 1996-01-29 CN CN96191750A patent/CN1083263C/en not_active Expired - Lifetime
- 1996-01-29 EE EE9700166A patent/EE03384B1/en not_active IP Right Cessation
- 1996-01-29 JP JP52338596A patent/JP4516159B2/en not_active Expired - Lifetime
- 1996-01-29 SK SK1030-97A patent/SK284521B6/en unknown
- 1996-01-29 PL PL96321630A patent/PL183148B1/en unknown
- 1996-01-29 CZ CZ19972405A patent/CZ291349B6/en not_active IP Right Cessation
- 1996-01-29 AU AU44574/96A patent/AU695366B2/en not_active Expired
- 1996-04-12 TW TW085104319A patent/TW483757B/en not_active IP Right Cessation
-
1997
- 1997-07-24 LV LVP-97-144A patent/LV11940B/en unknown
- 1997-07-25 IS IS4532A patent/IS1980B/en unknown
- 1997-07-30 DK DK199700896A patent/DK176081B1/en not_active IP Right Cessation
- 1997-07-30 BG BG101803A patent/BG62876B1/en unknown
- 1997-07-31 FI FI973185A patent/FI119586B/en not_active IP Right Cessation
- 1997-07-31 NO NO19973531A patent/NO312814B1/en not_active IP Right Cessation
- 1997-08-01 LU LU90118A patent/LU90118B1/en active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0518468A1 (en) * | 1991-05-09 | 1992-12-16 | Neurim Pharmaceuticals (1991) Limited | Melatonin containing compositions |
EP0513702A2 (en) * | 1991-05-13 | 1992-11-19 | I.F.L.O. ISTITUTO FARMACOLOGICO LOMBARDO S.A.S. di Giorgio & Aldo Laguzzi & C. | Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2165910T3 (en) | NASAL AND OCULAR CETAMINE ADMINISTRATION FOR THE TREATMENT OF PAIN AND FOR DETOXIFICATION. | |
PT913156E (en) | USE OF PROTEIN C ACTIVATED TO TREAT HYPERCERAGULATE STATES ASSOCIATED WITH SEPSIA | |
NO20101190L (en) | Use of buprenorphine in the manufacture of a medicament | |
PT613371E (en) | NEW COMBINATION OF FORMOTEROL AND BUDSONIDO | |
NO306377B1 (en) | Dosage form for delivery of a drug | |
HU9301978D0 (en) | Application of complementary inhibitors in medical preparatives used for treatment of inflammatory diseases of intestines and skin | |
HUT77380A (en) | Use of a pharmaceutical combination for the treatment of multiple sclerosis (ms) and other demyelinating conditions | |
CZ176495A3 (en) | The use of riluzol for preparing a medicament suitable for treating parkinson's disease and parkinson's syndromes | |
MD1716C2 (en) | Use of melatonin for treatment of patients dependent on benzodiazepine | |
BG106171A (en) | Compositions and uses of et743 for treating cancer | |
ES2139842T3 (en) | USE OF MELATONIN TO TREAT PATIENTS WHO SUFFER DRUG DEPENDENCE. | |
FI973023A0 (en) | Combined therapeutic treatment of hyperproliferative disorders | |
BR0009380A (en) | Improved cancer treatment with temozozomide | |
EP0147185A3 (en) | Therapeutic use of cytidyl disphosphocholine to increase neuronal acetylcholine | |
NZ307601A (en) | Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions | |
AU6432899A (en) | Use of metformin to counteract weight gain associated with valproate and other psychotropic medications | |
SE9000207D0 (en) | MEDICINAL PRODUCTS AND THE USE OF THE SAME | |
NO984651L (en) | Use of benzone-offset derivatives for the manufacture of drugs for the treatment of central nervous system diseases | |
KR960003718A (en) | Use of Ifenprodil and its Diastereomers for the Preparation of Medicines Useful for the Treatment of Peripheral and Central Neurodegenerative Diseases | |
SE9101341D0 (en) | NEW MEDICINAL USE | |
UA29589A (en) | “inhapin” broncholytic drug | |
Hole et al. | Special depression treatment wards in the Federal Republic of Germany: A survey. | |
HUP9900627A2 (en) | Use of melatonin for producing pharmaceutical compositions suitable for treating patients suffering from drug addiction | |
EP1264601A3 (en) | Treatment of a coronary condition by delivery of therapeutics to the pericardial space | |
Cheng | Benefits of combination therapy confirmed |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD99 | Pending application | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |